Terns Pharmaceuticals, Inc. ( TERN) - Stock Earnings
Stock symbol TERN is outdated, potentially delisted? Maybe it is available on other exchange?
TERN Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q2 | -24.1 million USD | — USD |
| 2025Q3 | -24.6 million USD | — USD |
| 2025Q4 | -23.6 million USD | — USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
TERN Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -90.2 million USD | — USD |
| 2024 | -88.9 million USD | — USD |
| 2025 | -96.2 million USD | — USD |
| 2026 Est. | — | — |
TERN
Price: $52.95
52 week price:
Earnings Per Share: -1.03 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 59800
Market Capitalization: 6.1 billion